Protalix BioTherapeutics (PLX)
Develops and manufactures plant-cell-derived enzyme therapies for rare diseases.
$2.79
vs last close−0.05 (−1.76%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
in 50 days
EPS estimate
−$0.02
Revenue estimate
$12.4M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.09−$0.05$0.00$0.03−$0.07$0.22$0.05Pending
Estimate$0.07$0.08$0.03$0.06$0.01−$0.01−$0.01−$0.02
Surprise+28.6%−162.5%−93.3%−50.0%−800.0%+2,300.0%+600.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$18.2M$10.1M$15.7M$17.9M$9.1M$33.8M$19.9MPending
Estimate$21.6M$23.1M$13.5M$14.2M$18.3M$11.5M$13.0M$12.4M
Surprise−15.7%−56.2%+16.1%+25.3%−50.1%+193.5%+53.6%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.06 | — | — |
| Sep 2027 | $0.03 | — | — |
| Jun 2027 | $0.01 | — | — |
| Mar 2027 | $0.01 | — | — |
| Dec 2026 | −$0.02 | — | — |
| Nov 2026 | −$0.02 | — | — |
| Aug 2026 | −$0.01 | $0.05 | +600.0% |
| May 2026 | −$0.01 | $0.22 | +2,300.0% |
| Mar 2026 | $0.01 | −$0.07 | −800.0% |
| Nov 2025 | $0.06 | $0.03 | −50.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.06 | — | — | $20.9M | — | — | — |
| Sep 2027 | $0.03 | — | — | $18.8M | — | — | — |
| Jun 2027 | $0.01 | — | — | $17.5M | — | — | — |
| Mar 2027 | $0.01 | — | — | $15.5M | — | — | — |
| Dec 2026 | −$0.02 | — | — | $16.1M | — | — | — |
| Nov 12, 2026 | −$0.02 | — | — | $12.4M | — | — | — |
| Aug 12, 2026 | −$0.01 | $0.05 | +600.0% | $13.0M | $19.9M | +53.6% | +7.8% |
| May 13, 2026 | −$0.01 | $0.22 | +2,300.0% | $11.5M | $33.8M | +193.5% | +1.1% |
| Mar 18, 2026 | $0.01 | −$0.07 | −800.0% | $18.3M | $9.1M | −50.1% | −20.8% |
| Nov 13, 2025 | $0.06 | $0.03 | −50.0% | $14.2M | $17.9M | +25.3% | −9.8% |
| Aug 14, 2025 | |||||||
| May 9, 2025 | |||||||
| Mar 17, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 10, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 27, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 14, 2021 | |||||||
| Mar 30, 2021 | |||||||
| Oct 29, 2020 | |||||||
| Aug 10, 2020 | |||||||
| Jun 1, 2020 | |||||||
| Mar 12, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 6, 2019 | |||||||
| Mar 18, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 9, 2018 | |||||||
| Mar 6, 2018 | |||||||
| Nov 8, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 16, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 8, 2016 | |||||||
| May 9, 2016 | |||||||
| Mar 8, 2016 | |||||||
| Nov 9, 2015 | |||||||
| Aug 10, 2015 |